Synthetic nonapeptide for use as an adjuvant
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 27, 1993
Grant Date -
N/A
app pub date -
Feb 12, 1988
filing date -
Feb 20, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The specification relates to a synthetic peptide converted into a salt comprising one or more amine groups and capable of potentiating in vivo the primary and secondary antibody response to thymo-dependent and thymo-independent antigens having low immunogenicity. Injectable preparations comprising a solution of the peptide in a pharmacologically acceptable solvent are particularly useful as adjuvants in therapy.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully